State Of Alaska, Department Of Revenue Amgen Inc Transaction History

State Of Alaska, Department Of Revenue

  • $9.42 Billion
  • Q3 2024

A detailed history of State Of Alaska, Department Of Revenue transactions in Amgen Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 76,404 shares of AMGN stock, worth $19.8 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
76,404
Previous 69,614 9.75%
Holding current value
$19.8 Million
Previous $21.8 Million 13.18%
% of portfolio
0.26%
Previous 0.24%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
BUY
$309.38 - $337.38 $2.1 Million - $2.29 Million
6,790 Added 9.75%
76,404 $24.6 Million
Q2 2024

Aug 05, 2024
SELL
$262.75 - $319.31 $2.65 Million - $3.22 Million
-10,072 Reduced 12.64%
69,614 $21.8 Million
Q1 2024

Apr 19, 2024
BUY
$268.87 - $324.56 $1.86 Million - $2.24 Million
6,900 Added 9.48%
79,686 $22.7 Million
Q4 2023

Jan 19, 2024
SELL
$255.7 - $288.46 $956,318 - $1.08 Million
-3,740 Reduced 4.89%
72,786 $21 Million
Q3 2023

Oct 16, 2023
SELL
$218.65 - $271.46 $567,396 - $704,438
-2,595 Reduced 3.28%
76,526 $20.6 Million
Q2 2023

Jul 24, 2023
SELL
$214.27 - $253.37 $2.55 Million - $3.01 Million
-11,895 Reduced 13.07%
79,121 $17.6 Million
Q1 2023

Apr 17, 2023
SELL
$225.79 - $275.2 $221,274 - $269,696
-980 Reduced 1.07%
91,016 $22 Million
Q4 2022

Jan 11, 2023
BUY
$229.03 - $291.01 $174,749 - $222,040
763 Added 0.84%
91,996 $24.2 Million
Q3 2022

Oct 20, 2022
SELL
$224.46 - $253.15 $747,676 - $843,242
-3,331 Reduced 3.52%
91,233 $20.6 Million
Q2 2022

Jul 08, 2022
SELL
$230.71 - $256.74 $3.8 Million - $4.23 Million
-16,485 Reduced 14.84%
94,564 $23 Million
Q1 2022

Apr 14, 2022
SELL
$219.27 - $242.57 $1.09 Million - $1.21 Million
-4,985 Reduced 4.3%
111,049 $26.9 Million
Q4 2021

Jan 12, 2022
SELL
$198.88 - $227.6 $2 Million - $2.29 Million
-10,071 Reduced 7.99%
116,034 $26.1 Million
Q3 2021

Oct 07, 2021
SELL
$212.27 - $248.7 $1.47 Million - $1.73 Million
-6,943 Reduced 5.22%
126,105 $26.8 Million
Q2 2021

Jul 12, 2021
SELL
$233.58 - $259.14 $72,643 - $80,592
-311 Reduced 0.23%
133,048 $32.4 Million
Q1 2021

Apr 09, 2021
SELL
$221.91 - $258.6 $1.03 Million - $1.21 Million
-4,661 Reduced 3.38%
133,359 $33.2 Million
Q4 2020

Jan 08, 2021
SELL
$216.38 - $257.67 $3.2 Million - $3.81 Million
-14,787 Reduced 9.68%
138,020 $31.7 Million
Q3 2020

Oct 05, 2020
BUY
$234.65 - $260.95 $4.63 Million - $5.14 Million
19,716 Added 14.81%
152,807 $38.8 Million
Q2 2020

Jul 06, 2020
BUY
$197.81 - $242.74 $5.06 Million - $6.2 Million
25,557 Added 23.77%
133,091 $31.4 Million
Q1 2020

Apr 06, 2020
BUY
$182.24 - $241.7 $863,999 - $1.15 Million
4,741 Added 4.61%
107,534 $21.8 Million
Q4 2019

Jan 07, 2020
SELL
$189.21 - $243.2 $1.71 Million - $2.2 Million
-9,043 Reduced 8.09%
102,793 $24.8 Million
Q3 2019

Oct 02, 2019
BUY
$174.11 - $208.62 $3.41 Million - $4.09 Million
19,592 Added 21.24%
111,836 $21.6 Million
Q2 2019

Jul 23, 2019
BUY
$166.7 - $195.41 $128,692 - $150,856
772 Added 0.84%
92,244 $17 Million
Q1 2019

Apr 09, 2019
SELL
$180.87 - $203.88 $702,860 - $792,277
-3,886 Reduced 4.08%
91,472 $17.4 Million
Q4 2018

Jan 10, 2019
SELL
$178.4 - $208.25 $154,851 - $180,761
-868 Reduced 0.9%
95,358 $18.6 Million
Q3 2018

Oct 09, 2018
SELL
$185.29 - $208.89 $221,606 - $249,832
-1,196 Reduced 1.23%
96,226 $19.9 Million
Q2 2018

Jul 10, 2018
BUY
$166.05 - $186.51 $2.88 Million - $3.24 Million
17,350 Added 21.67%
97,422 $18 Million
Q1 2018

Apr 19, 2018
BUY
$169.43 - $198.0 $1.32 Million - $1.54 Million
7,790 Added 10.78%
80,072 $13.6 Million
Q4 2017

Jan 19, 2018
BUY
$168.79 - $188.59 $11.1 Million - $12.4 Million
65,752 Added 1006.92%
72,282 $12.6 Million
Q3 2017

Oct 16, 2017
BUY
$167.29 - $191.0 $1.09 Million - $1.25 Million
6,530
6,530 $1.22 Million

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $139B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email